1. LB0002 Safety and Tolerability of Arimoclomol in Patients with Sporadic Inclusion Body Myositis: A Randomised, Double-Blind, Placebo-Controlled, Phase IIa Proof-of-Concept Trial. (23rd January 2014) Authors: Machado, P.; Miller, A.; Herbelin, L.; He, J.; Noel, J.; Wang, Y.; McVey, A. L.; Pasnoor, M.; Gallagher, P.; Statland, J.; Brady, S.; Lu, C.-H.; Kalmar, B.; Sethi, H.; Samandouras, G.; Holton, J.; Greensmith, L.; Barohn, R. J.; Hanna, M. G.; Dimachkie, M. M. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0035 Progress Report on the Development of New Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies. (23rd January 2014) Authors: Tjärnlund, A.; Bottai, M.; Rider, L. G.; Werth, V. P.; Pilkington, C.; de Visser, M.; Alfredsson, L.; Amato, A. A.; Barohn, R. J.; Liang, M. H.; Singh, J. A.; Miller, F. W.; Lundberg, I. E. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗